Especially, a significant correlation between the expression of IL1β and bone metastasis has been reported: 37% of patients with IL1β-positive primary tumours developed bone metastasis compared with 5% of patients with IL1β-negative primary tumours [3]. The gene discussed is IL1B; the disease is neoplasm.